Novo Nordisk's total assets for Q2 2026 were kr594.94B, an increase of 6.39% from the previous quarter. MX:NVON total liabilities were kr373.66B for the fiscal quarter, a 4.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.